International Conference and Exhibition on Genome Science conference aims to provide a platform for Scientists, Researchers, Professors, Policy Makers, Technology developers, Students, Exhibitors, Entrepreneurs, Academicians, Medical representatives, to exchange information on latest research trends in Genome Science. The participants of the conference forum actively engage in research discussions, professional development and create opportunities for the next generation workforce to develop their professional skills. Participants from the top international universities, government, and private organizations participate in International Conference and Exhibition on Genome Science to identify development tools, new technology trends, R&D collaborations and product opportunities.
International Conference and Exhibition on Genome Science will cover a wide range of current research and interdisciplinary topics related to the field of Genome Science.
This conference includes keynote lectures, plenary lectures, invited talks by eminent personalities, oral & poster presentations, it is an excellent opportunity for students to meet and discuss with lead researchers. It serves the information needs of business, public communities, academics & government.
Dear Friends & Colleagues
On behalf of the organizing committee, we are pleased to announce that the INTERNATIONAL CONFERENCE AND EXHIBITION ON GENOME SCIENCE will take place Jan 29-31 2018, in Las Vegas, USA. ICEGS-2018 provides a unique opportunity for Scientists, researchers, specialists, clinicians, Counselors, Entrepreneurs, Professors, Technology developers, Academicians, Exhibitors, Lab technicians, Policymakers and other genetics professionals and shares the latest discoveries and developments in genome research.
With the participation of outstanding international experts are coming together to bring their depth of knowledge and experience to their research- Bioinformatics, cancer genetics, clinical genetics, cytogenetics, epigenetics, evolutionary and population genetics, engineering genetics, Metabolic disorders, Pharmacogenetics, Neurogenetics, Statistical genetics, Plant genetics and Therapy for genetic disorders etc…
we hope productive discussions would stimulate new creative ideas to translate new discoveries into better research in genome science. In addition to the dynamic scientific program, you will benefit from the wonderful experience in Las Vegas, USA.
We cordially invite you to participate and contribute to the success of this event.Your presence will be our pleasure
|
Day – 1 |
Monday, January 29th, 2018 |
|
08:30 am – 09:00 am |
Registration Desk Opens |
|
09:00 am – 10:00 am |
Welcome Message |
|
10:00 am – 10:30 pm |
Networking Coffee Break & Exhibition Visit |
|
10:30 am – 12:30 pm |
Scientific Session 1 |
|
12:30 pm – 01:30 pm |
Networking Lunch & Exhibition Visit |
|
01:30 pm – 03:30 pm |
Poster Session 1 |
|
03:30 pm – 04:00 pm |
Networking Coffee Break & Exhibition Visit |
|
04:00 pm – 06:00 pm |
Scientific Session 2 |
|
Day – 2 |
Tuesday, January 30th, 2018 |
|
09:00 am – 10:30 am |
Scientific Session 3 |
|
10:30 am – 11:00 am |
Networking Coffee Break & Exhibition visit |
|
11:00 am – 12:30 pm |
Poster Session 2 |
|
12:30 am – 01:30 pm |
Networking Lunch & Exhibition Visit |
|
01:30 pm – 03:00 pm |
Poster presentation 3 |
|
03:00 pm – 03:30 pm |
Networking Coffee Break & Exhibition visit |
|
03:30 pm – 06:00 pm |
Scientific Session 4 |
|
Day – 3 |
Wednesday, January 31st, 2018 |
|
09:00 am – 10:30 am |
Scientific Session 5 |
|
10:30 am – 11:00 am |
Networking Coffee Break & Exhibition visit |
|
11:00 am – 12:30 pm |
Poster Session 4 |
|
12:30 am – 01:30 pm |
Networking Lunch & Exhibition Visit |
|
01:30 pm – 03:00 pm |
Scientific Session 6 |
|
03:00 pm – 03:30 pm |
Networking Coffee Break & Exhibition visit |
|
03:30 pm – 06:00 pm |
Scientific Session 7 |
|
Award ceremony |
|
|
Conference Concludes |
|
|
Conference Details |
Dates |
|
1st Round Abstract Submission opens |
1 June 2017 |
|
1st Round Abstract Submission Deadline |
30 July 2017 |
|
Early Bird Registrations Opens |
15 June 2017 |
|
Early Bird Registration Deadline |
15 Nov 2017 |
|
Group Registration Deadline |
30 Nov 2017 |
|
Exhibitor Opportunity Ends |
15 Dec 2017 |
|
Sponsorship request Deadline |
15 Dec 2017 |
|
workshop request Submission |
Till 15 Dec 2017 |
|
Symposium Submission Deadline |
15 Dec 2017 |
|
Media Partner request Till |
15 Dec 2017 |
|
Advertising Opportunity Request |
15 Dec 2017 |
|
Volunteer Opportunity Ends |
1 Dec 2017 |
|
Press pass Opportunity Deadline |
1 Dec 2017 |
|
Presentation Dates |
29-31 Jan 2018 |
|
(a) |
Cancer genome analysis, sequencing, and alignment |
|
(b) |
Systems Biology & Systems Pharmacology |
|
(c) |
genome-wide association studies and Cell fate in cancer |
|
(d) |
Personal genome screening |
|
(e) |
Sequencing mutations or somatic cancer genetic studies |
|
(f) |
Epigenetic changes in cancer and Cancer epidemiology |
|
(g) |
Cancer Nanotheranostics, genome therapy, and Biopsy |
|
(h) |
Cancer Model Systems & Integrated Analyses of Cancer |
|
(i) |
Translation & Clinical Impact of Cancer Genomics |
|
(j) |
Tumor Hetero genetics |
|
(k) |
Cancer Metabolism |
| (l) | Other |
Submit Your Abstract Suggest Your session
|
(a) |
Computational genomics and proteomics |
|
(b) |
Tools for functional and comparative genomics |
|
(c) |
Genome sequencing and assembly |
|
(d) |
Bio data mining and Data integration methods |
|
(e) |
Cloud and workflow platforms for bioinformatics |
|
(f) |
Genome analysis and Phylogeny |
|
(g) |
Exploratory analysis of biological data using R |
|
(h) |
Bioinformatics for cancer genomics |
|
(i) |
Genomics organism model |
|
(j) |
Technology advancement |
|
(k) |
System biology and genetics |
|
(l) |
Molecular modeling and drug designing |
|
(m) |
Other |
Submit Your Abstract Suggest Your session
|
(a) |
Chromosomal disorders and gene therapy for cancer treatment |
|
(b) |
Clinical gene therapy and genomics healthcare |
|
(c) |
Laboratory experiences regarding genetic, genomic testing and screening |
|
(d) |
Molecular genetics of complex diseases |
|
(e) |
Tools and techniques in clinical genetics |
|
(f) |
Other |
Submit Your Abstract Suggest Your session
|
(a) |
Cancer evolutionary genomics |
|
(b) |
Gene cluster and Gene Rearrangement |
|
(c) |
Genomic Variation |
|
(d) |
Gene Order and Phylogenetic reconstruction |
|
(e) |
Algorithms for genome evolution |
|
(f) |
Comparative tools for genome assembly |
|
(g) |
Other |
|
(a) |
Plant taxonomy and ecology |
|
(b) |
Plant pathology and physiology |
|
(c) |
Plant breeding and crop breeding |
|
(d) |
Transgenic Plants |
|
(e) |
Plant Epigenetics and plant science |
|
(f) |
Crop protection and management |
|
(g) |
Weed Science and rice genome |
|
(h) |
Tissue culture and plant biotechnology |
|
(i) |
Breeding Genomics |
|
(j) |
Plant Physiology |
|
(k) |
other |
Submit Your Abstract Suggest Your session
|
(a) |
Human genome engineering |
|
(b) |
Multiplex Automated Genomic Engineering |
|
(c) |
Genome Profiling |
|
(d) |
CRISPR/CAS Revolution in Genome Engineering |
|
(e) |
Induced Pluripotent Stem Cell Technology |
|
(f) |
Targeted Genome Editing |
|
(g) |
Plant Genome Engineering and Genome Reprogramming |
|
(h) |
Advances in Genome Editing |
|
(i) |
Other |
|
(a) |
Biological and small molecule therapeutics |
|
(b) |
Functional studies of associated variants or loci |
|
(c) |
Genome-wide association studies |
|
(d) |
Pharmacogenitics & Individualized therapy |
|
(e) |
Pharmacodynamics |
|
(f) |
Nutrigenomics and Toxicogenomics |
|
(g) |
Sequencing studies/rare variants |
|
(h) |
Biomarker translation and testing |
|
(i) |
Small molecule screening and in vitro |
|
(j) |
Other |
|
(a) |
Drug treatments |
|
(b) |
Enzyme replacement therapy |
|
(c) |
Gene therapy |
|
(d) |
Gene-based therapeutics for neurological disorders |
|
(e) |
Characterization of new disorders |
|
(f) |
Cell therapy terminology |
|
(g) |
Biochemical basis of disease |
|
(h) |
Clinical Metabolic and Lipidomics |
|
(i) |
Hemophilia therapy |
|
(j) |
Diagnostic methods |
|
(k) |
Other |
|
(a) |
Assisted reproductive technologies |
|
(b) |
Preimplantation diagnosis |
|
(c) |
Fetal imaging |
|
(d) |
Genetic screening |
|
(e) |
Gynecologic complications |
|
(f) |
Preterm birth |
|
(g) |
Infertility |
|
(h) |
Maternal serum screening |
|
(i) |
Prenatal diagnosis |
|
(j) |
Other |
|
(a) |
Chromosome structure |
|
(b) |
Copy number/structural genomic variation |
|
(c) |
Cytogenetic studies |
|
(d) |
Molecular cytogenetic technologies (eg, FISH, microarrays, etc.) |
|
(e) |
Other |
|
(a) |
Clinical Epigenetics |
|
(b) |
X-inactivation |
|
(c) |
Histone modification |
|
(d) |
Twin studies |
|
(e) |
Imprinting |
|
(f) |
DNA methylation |
|
(g) |
Other |
|
(a) |
Evolution: Experimental, Genome, Ecological, and Molecular |
|
(b) |
Comparative Genomics, Computational Methods, and Evolution |
|
(c) |
Mutation and Recombination |
|
(d) |
Linkage disequilibrium/recombination |
|
(e) |
Rare variants |
|
(f) |
Molecular evolution |
|
(g) |
Mutation and polymorphism |
|
(h) |
Natural selection and adaptation |
|
(i) |
Quantitative Traits, Adaptation, and Speciation |
|
(j) |
Population history and relationships |
|
(k) |
Population isolates and founder mutations |
|
(l) |
Other |
|
(a) |
Transcription regulation |
|
(b) |
Genomic Sequencing |
|
(c) |
Posttranscriptional regulation/RNA editing |
|
(d) |
Functional genomics and bioinformatics |
|
(e) |
Genomic responses in differentiation, disease, stress or stimulation |
|
(f) |
Chromatin characteristics/nuclear organization |
|
(g) |
Copy number variation |
|
(h) |
Chromatin & Epigenetics |
|
(i) |
Microbiomes |
|
(j) |
Other |
|
(a) |
Annotated sequences of cattle |
|
(b) |
Regulation of genes in livestock |
|
(c) |
Microbial genetics |
|
(d) |
Ecoli Genome and Genomics |
|
(e) |
Bacterial and viral Genomic |
|
(f) |
Buffalo and poultry genomes |
|
(h) |
Other |
|
(a) |
Statistical analysis programs/software |
|
(b) |
Analysis of risk, genotype or phenotype, penetrance and individual variants association methods |
|
(c) |
Study Design, Quality control, Pre-Processing, Population Stratification adjustments |
|
(d) |
Family-based association, identity-by-descent, linkage or segregation methods |
|
(e) |
Pathway, network, Systems Analysis, Gene x Gene and Gene x Environment Analysis |
|
(f) |
Other |
|
(a) |
Genome-wide association studies |
|
(b) |
Development |
|
(c) |
Tandem repeats, triplet expansions, and disease |
|
(d) |
Diagnostic methods |
|
(e) |
Functional studies of associated variants or loci |
|
(f) |
Gene-environment interactions |
|
(g) |
Neuroimaging genetics |
|
(h) |
Predictors of progression and response to treatment |
|
(i) |
Other |
|
(a) |
Continuing/professional |
|
(b) |
Graduate and medical |
|
(c) |
Public |
|
(d) |
Undergraduate |
|
(e) |
Other |
|
(a) |
Candidate genes/regions and fine mapping |
|
(b) |
Model systems of complex disease or gene interactions |
|
(c) |
Missing heritability |
|
(d) |
Gene/environment interactions |
|
(e) |
Pathway network/system genetics analyses of traits/diseases |
|
(f) |
Joint application of statistical and molecular methods |
|
(g) |
Other |
|
(a) |
Data sharing and privacy issues |
|
(b) |
Informed consent |
|
(c) |
Policy, legal and regulatory issues |
|
(d) |
Return of genetic test results |
|
(e) |
Social and cultural implications of genetic and genomic technologies |
|
(f) |
Other |
|
(a) |
Genetic counseling |
|
(b) |
Molecular pharming |
|
(c) |
Genetic epidemiology and pharmacoepidemiology |
|
(d) |
Synthetic biology and bioengineering |
|
(e) |
Translational genetics and genomics |
|
(f) |
Phenomics |
|
(g) |
Other |
